People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Selecta Biosciences Inc | — | Biotechnology | Series D+ | $445.6M | $1.4B | 2024 |
| Tectonic Therapeutic, Inc. | — | Biotechnology | Series D+ | $333.1M | $1.7B | 2021 |
| Morphic Holding, Inc. | — | Biotechnology | Series C | $200.6M | $1.5B | 2023 |
| Seismic Therapeutic, Inc. | — | Biotech / Pharma | Series D+ | $146.3M | $1.9B | 2023 |
Timothy A. Springer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy A. Springer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Praveen P. Tipirneni | 2 | 2 |
| Carl Gordon | 1 | 24 |
| Kevin Bitterman | 1 | 15 |
| Peter Barton Hutt | 1 | 14 |
| Amir Nashat | 1 | 14 |
| Joshua Resnick | 1 | 12 |
| Bruce Booth | 1 | 12 |
| Shelley Chu | 1 | 10 |
| Alan Crane | 1 | 9 |
| Terry McGuire | 1 | 8 |
| CARL L. GORDON | 1 | 7 |
| Bruce Rogers | 1 | 7 |
| Scott Requadt | 1 | 5 |
| Vikas Goyal | 1 | 5 |
| Ian Clark | 1 | 5 |
| Werner Cautreels | 1 | 5 |
| Ramy Farid | 1 | 5 |
| Andrew Hedin | 1 | 5 |
| Robert Farrell | 1 | 4 |
| Edwin M. Kania, Jr. | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.